Atossa Therapeutics, Inc.
SUSTAINED RELEASE COMPOSITIONS OF ENDOXIFEN
Last updated:
Abstract:
The present disclosure provides sustained release compositions of (Z)-endoxifen and polymorphs and salts thereof and methods of making sustained release compositions of (Z)-endoxifen and polymorphs and salts thereof. The present disclosure also provides methods for treating disorders susceptible to (Z)-endoxifen, including hormone dependent disorders and mood disorders.
Status:
Application
Type:
Utility
Filling date:
2 Jul 2020
Issue date:
9 Jun 2022